99.7% Sustained Virologic Response Rate in 369 HCV Genotype 1b‐Infected Patients Treated With Label‐Recommended Regimen of Ombitasvir/Paritaprevir/r and Dasabuvir With or Without Ribavirin: 2016. (October 2015) - Jacobson, Ira M.; Dufour, Jean‐Francois; Wedemeyer, Heiner; Bernstein, David; Colombo, Massimo; Romero‐ Gómez, Manuel; Reau, Nancy; Trinh, Roger; Xie, Wangang; Enejosa, Jeffrey; Cohen, Daniel; Martinez, Marisol